受强制性开放获取政策约束的文章 - Masayuki Kurosaki了解详情
无法在其他位置公开访问的文章：3 篇
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
JM Llovet, M Kudo, P Merle, T Meyer, S Qin, M Ikeda, R Xu, J Edeline, ...
The Lancet Oncology 24 (12), 1399-1410, 2023
强制性开放获取政策： Cancer Research UK
Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction‐associated steatotic liver disease
N Tamaki, SI Wakabayashi, T Kimura, Y Yasui, K Tsuchiya, H Nakanishi, ...
Hepatology Research, 2024
强制性开放获取政策： National Medical Research Council, Singapore
Carrier Frequency Offset Effects on the Self-Interference Cancellation using Null Beamforming
MHB PRATAMA, Y NAGAO, M KUROSAKI, H OCHI
强制性开放获取政策： Japan Science and Technology Agency
可在其他位置公开访问的文章：11 篇
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter …
T Mashiba, K Joko, M Kurosaki, H Ochi, Y Osaki, Y Kojima, R Nakata, ...
PLoS One 13 (4), e0194704, 2018
强制性开放获取政策： Forskningsrådet för arbetsliv, hälsa och välfärd
Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality
M Higuchi, N Tamaki, M Kurosaki, K Inada, S Kirino, K Yamashita, ...
Alimentary pharmacology & therapeutics 55 (3), 292-301, 2022
强制性开放获取政策： US National Institutes of Health
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
N Tamaki, M Kurosaki, DQ Huang, R Loomba
Hepatology Research 52 (6), 497-507, 2022
强制性开放获取政策： US National Institutes of Health
Change in fibrosis 4 index as predictor of high risk of incident hepatocellular carcinoma after eradication of hepatitis C virus
N Tamaki, M Kurosaki, Y Yasui, N Mori, K Tsuji, C Hasebe, K Joko, ...
Clinical Infectious Diseases 73 (9), e3349-e3354, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Risk difference of liver-related and cardiovascular events by liver fibrosis status in nonalcoholic fatty liver disease
N Tamaki, M Higuchi, M Kurosaki, R Loomba, N Izumi, K Inada, S Kirino, ...
Clinical Gastroenterology and Hepatology 20 (5), 1171-1173. e2, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Two-step strategy, FIB-4 followed by magnetic resonance elastography, for detecting advanced fibrosis in NAFLD
N Tamaki, K Imajo, SR Sharpton, J Jung, N Sutter, N Kawamura, ...
Clinical Gastroenterology and Hepatology 21 (2), 380-387. e3, 2023
强制性开放获取政策： US National Institutes of Health
Hepatocellular carcinoma risk assessment for patients with advanced fibrosis after eradication of hepatitis C virus
N Tamaki, M Kurosaki, Y Yasui, N Mori, K Tsuji, C Hasebe, K Joko, ...
Hepatology Communications 6 (3), 461-472, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Reply to:“Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR”
M Kurosaki, N Izumi
Journal of hepatology 55 (5), 1164-1166, 2011
强制性开放获取政策： US National Institutes of Health
The evolutionary patterns of hepatitis C virus subtype 2a and 6a isolates linked to an outbreak in China in 2012
L Lu, Y An, J Zou, L Gu, Z Zhao, X Zhang, C Li, C Kurihara, R Hokari, ...
Virology 485, 431-438, 2015
强制性开放获取政策： US National Institutes of Health
Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B
S Kirino, N Tamaki, M Kurosaki, S Kaneko, K Inada, Y Tanaka, S Ishido, ...
Hepatology Research 53 (1), 35-42, 2023
强制性开放获取政策： Japan Science and Technology Agency
Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population
S Kirino, N Tamaki, M Kurosaki, Y Takahashi, M Higuchi, Y Itakura, ...
Quantitative Imaging in Medicine and Surgery 13 (10), 6493, 2023
强制性开放获取政策： Japan Science and Technology Agency
出版信息和资助信息由计算机程序自动确定